# CLARET BIOSCIENCE, LLC: A cfDNA methylo-fragmentomic assay for prediction of risk-progression in Prostate Cancer

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | CLARET BIOSCIENCE, LLC |
| Location | BIRMINGHAM, MI |
| Project | A cfDNA methylo-fragmentomic assay for prediction of risk-progression in Prostate Cancer |
| Project number | 1R43CA314763-01 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $385,919 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-18 to 2027-08-31 |
| UEI | NBKDPRMF8Y27 |

## Why this score
- Award of $385,919.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11407859). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.